International Trade Commission October 20, 2011 – Federal Register Recent Federal Regulation Documents

Certain Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoetin; Termination of Investigation on the Basis of Settlement
Document Number: 2011-27167
Type: Notice
Date: 2011-10-20
Agency: International Trade Commission, Agencies and Commissions
Notice is hereby given that the U.S. International Trade Commission has determined to terminate the above-captioned investigation on the basis of settlement between the private parties.